has meant far more to Novartis than simply a product showcase. Over the past eight years, more than 40 innovative drugs and new indications have accelerated their approval in C
相关搜索
ces, and a feedback loop of innovation value. These long-term efforts are clearly reflected in its performance: in the first three quarters of 2025, Novartis China recorded $3.2
当前文章：http://7iw.ceqiaobai.cn/61mo/bbbu.html
发布时间：12:50:46
